Juha Andrew Clase

This inventor holds 13 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Pimco 2664 Limited, Janssen Pharmaceutica Nv, Galapagos Nv. Active years: 2009-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juha Andrew Clase. Retrieved from https://idiyas.com/inventor/juha-andrew-clase

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13

% Patents Active = 84.6

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 8.6

ph-index = 7

Forward Citations = 76(Granted Patents)

Location History:

Mechelen, BE (2009 - 2012)
Chappel-en-le-Frith, GB (2012)
Chapel-en-le-Frith, GB (2015)
High Peak, GB (2012 - 2017)

Company Filing History:

Janssen Pharmaceutica Nv

Years Active: 2009-2017

Loading Chart...

Areas of Expertise:

Aryl-Phenyl-Sulfonamido Compounds

Fused Pyrazine Compounds

Degenerative Diseases

Inflammatory Diseases

Triazolopyrazine Compounds

Imidazolopyrazine Compounds

Phenylene Compounds

Chemical Synthesis

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9616037 - Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use (2017-04-11),

2. 9302984 - Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use (2016-04-05),

3. 9050329 - Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use (2015-06-09),

4. 9006237 - Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases (2015-04-14),

5. 8822507 - Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use (2014-09-02),

6. 8435968 - Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use (2013-05-07),

7. 8207167 - Aryl-phenyl-sulfonamide-phenylene compounds and their use (2012-06-26),

8. 8178530 - Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases (2012-05-15),

9. 8173656 - Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases (2012-05-08),

10. 8148369 - Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases (2012-04-03),

11. 7915256 - Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases (2011-03-29),

12. 7893058 - Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases (2011-02-22),

13. 7501411 - Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases (2009-03-10),

Title: Juha Andrew Clase: Innovator in Therapeutic Compounds

Introduction

Juha Andrew Clase is a notable inventor based in High Peak, GB. He has made significant contributions to the field of therapeutic compounds, holding a total of 13 patents. His work focuses on innovative solutions for various medical conditions, particularly those related to inflammation and immune system disorders.

Latest Patents

One of Juha Andrew Clase's latest patents is centered around aryl-phenyl-sulfonamido-cycloalkyl compounds, collectively referred to as 'APSAC compounds'. This invention pertains to pharmaceutical compositions that utilize these compounds for treatment in both in vitro and in vivo settings. The applications of these compounds include addressing inflammation, joint destruction, and bone loss. They are also aimed at treating disorders mediated by excessive activation of the immune system, such as rheumatoid arthritis, psoriasis, and chronic obstructive pulmonary disease (COPD). Furthermore, these compounds are designed to combat various cancers, including haematological malignancies and solid tumors.

Career Highlights

Throughout his career, Juha Andrew Clase has worked with prominent companies in the pharmaceutical industry, including Pimco 2664 Limited and Janssen Pharmaceutica NV. His expertise in therapeutic compounds has positioned him as a key player in the development of innovative medical solutions.

Collaborations

Juha has collaborated with notable professionals in his field, including Martin James Inglis Andrews and Mark Stuart Chambers. These collaborations have further enhanced his contributions to the development of therapeutic compounds.

Conclusion

Juha Andrew Clase's work in the field of therapeutic compounds exemplifies innovation and dedication to improving health outcomes. His numerous patents and collaborations highlight his significant impact on medical research and development.

Profile summary based on public USPTO records.